Information

The Pennzoil Building, Suite 1300 North Tower 700 Milam

Houston TX 77002

410 350 1839

www.anthera.com

Industry: Biotechnology

Anthera Pharmaceuticals Inc

Description

Anthera Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of medicines for patients with unmet medical needs. It develops Sollpura, a non-porcine investigational pancreatic enzyme replacement therapy that is in Phase III clinical trial for the treatment of patients with exocrine pancreatic insufficiency; and Blisibimod, which is in Phase II clinical trial for the treatment of B-cell mediated autoimmune diseases, including immunoglobulin A nephropathy or IgA nephropathy. The company has license agreements with Amgen, Inc., and Eli Lilly and Company. Anthera Pharmaceuticals, Inc. was founded in 2004 and is based in Houston, Texas.

Click to get the best stock tips daily for free!
ABOUT ANTHERA PHARMACEUTICALS INC
Anthera Pharmaceuticals
Anthera Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of medicines for patients with unmet medical needs. It develops Sollpura, a non-porcine investigational pancreatic enzyme replacement therapy that is in Phase III clinical trial for the treatment of patients with exocrine pancreatic insufficiency; and Blisibimod, which is in Phase II clinical trial for the treatment of B-cell mediated auto...
GOLDEN STAR
Ticker Change Signal Date
T
TBIL
$49.90
0.0802% Feb 12
I
IBTF
$23.33
0.0429% Feb 12
SKT
$33.58
2.00% Feb 12
BSY
$46.63
1.33% Feb 11
IBN
$29.02
0.482% Feb 11

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE